Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
62,870.19 -1,236.44 (-1.93%) CMC Crypto 200
1,304.48 -92.06 (-6.59%)
Carmat SA (CXT.F)
| Previous close | 3.1550 |
| Open | 3.1200 |
| Bid | 3.1300 x 11300 |
| Ask | 3.1850 x 11100 |
| Day's range | 3.1000 - 3.1850 |
| 52-week range | 3.0000 - 9.4200 |
| Volume | |
| Avg. volume | 35 |
| Market cap | 91.918M |
| Beta (5Y monthly) | 1.31 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.1700 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireCARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024
PARIS, April 24, 2024--CARMAT announces its 2023 annual results and provides an update on its progress and prospects for 2024
Business WireCARMAT Announces Its Participation in Several Scientific and Investor Conferences During the Second Quarter of 2024
PARIS, April 04, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), announces today its participation in the following scientific and investor conferences during the second quarter of 2024:
Business WireCARMAT Announces a Final Agreement With All Its Financial Creditors on New Repayment Terms for Its Bank Loans
PARIS, March 22, 2024--Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure (the "Company" or "CARMAT"), today announces a final agreement with all its financial creditors on new loan repayment terms.
